NAV
₹47.2400
as of 17 Jun 2026
Expense Ratio
—
see scheme documents
Lumpsum returns (CAGR)
- 1Y
- +13.22%
- 3Y
- +24.93%
- 5Y
- +15.87%
- Since Inception
- +21.54%
SIP returns (XIRR)
- 1Y
- +18.20%
- 3Y
- +17.53%
- 5Y
- +18.42%
- Since Inception
- +21.37%
Performance Comparison
Sectoral allocation
as of 31 Mar 2026- Pharmaceuticals & Biotechnology78.00%
- Healthcare Services21.00%
- IT - Services1.00%
- Chemicals & Petrochemicals1.00%
Each sector links to the mutual funds most exposed to it.
Thinking about Mirae Asset Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with Mirae Asset Healthcare Fund -Regular Growth
- 1Sun Pharmaceutical Industries Ltd.12.20%
- 2Divi'S Laboratories Ltd.7.93%
- 3Glenmark Pharmaceuticals Ltd.6.94%
- 4Jb Chemicals & Pharmaceuticals Ltd.6.88%
- 5Apollo Hospitals Enterprise Ltd.6.15%
- 6Lupin Ltd.5.06%
- 7Aurobindo Pharma Ltd.4.32%
- 8Dr. Reddy'S Laboratories Ltd.4.31%
- 9Fortis Healthcare Ltd.3.73%
- 10Laurus Labs Ltd.3.56%
Investment Objective
Mirae Asset Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Mirae Asset Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Mirae Asset Mutual Fund. The fund has been operational for over 7 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations